No relevant pages have been found.
is one in a class of drugs known as 'PARP inhibitors' and was designed to treat breast cancer in women with faulty BRCA1 or BRCA2... breast cancer, PARP inhibitors,...
Nenalezena žádná pracoviště s požadovaným obsahem.
